The second edition of ISPM has just ended: the Summer School for Project Mangers promoted by CoEHAR and ECLAT has been a success, thanks to the exceptional partnership with PMI-SIC
The aim of the study is to investigate different in vitro toxicity methods for the assessment of ENDs toxicity. According to the Italian researchers, the most used assay, the neutral red uptake, should be combined with different tools (enlisted in the study) to better identifies the toxicity of the products and can avoid approximate and incorrect evaluation
A group of Harm Reduction experts and scientists discussed the latest news on THR during the virtual meeting GTNF In Focus: THR 2021
The Center of Excellence for the Acceleration of Harm Reduction (CoEHAR) is among the contributors for the drafting of the BECA Report by the Special Committee on Cancer of the European Parliament
The Center of Excellence for the Acceleration of Harm Reduction (CoEHAR) is pleased to present the "Smile Study", a new research project committed to reducing the damage caused by smoking…
A new study by CoEHAR, the "Role of Cigarette Smoke on Angiotensin-Converting Enzyme-2 Protein Membrane Expression in Bronchial Epithelial Cells Using an Air-Liquid Interface Model" investigates the molecular mechanisms that regulate the expression of the ACE2 enzyme, involved in Covid-19 infection
The new study by CoEHAR, "Nicotine dosimetry and stability in cambridge filter PADs (CFPs) following different smoking regime protocols and storage conditions", provided new guidelines for future multicentric studies in the low-risk products
Nicotine is a protective shield against the insurgence of severe symptoms of COVID-19. This is what emerged with the new study by CoEHAR
CoEHAR's researchers have just published the longest clinical follow-up of E-cigarette users ever reported. The study “COPD smokers who switched to e-cigarettes: health outcomes at 5-year follow up” explores the long term effects of E-cigarette use in patients with chronic obstructive pulmonary disease (COPD) and confirms that regular use can ameliorate objective and subjective COPD and is long lasting
Reflecting on the 15th Year of the World Health Organization’s Framework Convention on Tobacco Control (WHO FCTC), two international expert panel sessions featuring leading academics, researchers and NGO principals will cover the key questions and challenges facing policymakers in achieving more effective and equitable implementation globally
We will send you direct emails, without intermediary services, you can withdraw any time.
Copyright 2021 – Center of Excellence for the acceleration of Harm Reduction. All rights reserved.